AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15363656 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Pycnogenol for 12 weeks
Number of subjects: 77
Study 11180035 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tacrolimus (5 mg)
Number of subjects: 34
Study 11180035 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tacrolimus (0.015 mg/kg)
Number of subjects: 34
Study 9844958 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive patients (mI/Cr ratio in left frontal lobe: 0.43 +/- 0.06)
Number of subjects: 22
Study 9844958 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (mI/Cr ratio in left frontal lobe: 0.46 +/- 0.07)
Number of subjects: 22
Study 9844958 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive patients (mI/Cr ratio in right frontal lobe: 0.46 +/- 0.08)
Number of subjects: 22
Study 9844958 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (mI/Cr ratio in right frontal lobe: 0.48 +/- 0.06)
Number of subjects: 22
Study 9844958 — intervention group
Group type: EXPERIMENTAL
Intervention: Age matched pairs analysis of depressed patients (mI/Cr ratio in right frontal lobe: 0.40 +/- 0.05)
Number of subjects: 22
Study 9844958 — intervention group
Group type: COMPARATOR
Intervention: Age matched pairs analysis of healthy subjects (mI/Cr ratio in right frontal lobe: 0.45 +/- 0.06)
Number of subjects: 22
Study 8127015 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.21 +/- 0.02 microgram/day)
Number of subjects: 21
Study 8127015 — intervention group
Group type: COMPARATOR
Intervention: Control (no calcitriol treatment)
Number of subjects: 21
Study 2597240 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumping rope
Number of subjects: 30
Study 2597240 — intervention group
Group type: COMPARATOR
Intervention: Jumping in place (without a rope)
Number of subjects: 30
Study 15867103 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Employment (SE) program
Number of subjects: 1273
Study 15867103 — intervention group
Group type: COMPARATOR
Intervention: Control group (services as usual)
Number of subjects: 1273
Study 31828857 — intervention group
Group type: EXPERIMENTAL
Intervention: 600mg Trigonella foenum‐graecum per day
Number of subjects: 100
Study 31828857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29629505 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana dispensary websites
Number of subjects: 97
Study 28657604 — intervention group
Group type: EXPERIMENTAL
Intervention: RESMENA dietary group
Number of subjects: 70
Study 28657604 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit fiber consumption (≥8.8 g/day)
Number of subjects: 70
Study 28657604 — intervention group
Group type: COMPARATOR
Intervention: AHA dietary group
Number of subjects: 70
Study 25279689 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (treadmill training three times per week for 3 months) + vitamin B6 and Ca supplements
Number of subjects: 30
Study 25279689 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B6 and Ca supplements (control group)
Number of subjects: 30
Study 23865727 — intervention group
Group type: EXPERIMENTAL
Intervention: Zabofloxacin hydrochloride 400 mg capsule (DW224a)
Number of subjects: 32
Study 23865727 — intervention group
Group type: COMPARATOR
Intervention: Zabofloxacin aspartate 488 mg tablet (DW224aa)
Number of subjects: 32
Study 22096523 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-management program involving weekly online monitoring of asthma control with self-treatment advice, remote Web communications, and Internet-based information
Number of subjects: 0
Study 22096523 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 19338148 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpi Wenshen Recipe (JPWS) alone
Number of subjects: 51
Study 19338148 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpi Wenshen Recipe (JPWS) plus chemotherapy
Number of subjects: 51
Study 19338148 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 51
Study 16782097 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human FSH (rhFSH) at high doses (300 IU on alternate days) for a period of >or=4 months
Number of subjects: 30
Study 15220503 — intervention group
Group type: EXPERIMENTAL
Intervention: RF introducer with handheld system
Number of subjects: 99
Study 15220503 — intervention group
Group type: COMPARATOR
Intervention: Handheld system alone (control group)
Number of subjects: 99
Study 11252459 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee brace for three weeks postoperatively
Number of subjects: 50
Study 11252459 — intervention group
Group type: COMPARATOR
Intervention: No knee brace (rehabilitated without the use of a brace)
Number of subjects: 50
Study 9250802 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of fever, spleen enlargement, anemia, leukopenia, poor performance status, and poor histologic subgroups
Number of subjects: 130
Study 9250802 — intervention group
Group type: EXPERIMENTAL
Intervention: Fever, spleen involvement, leukopenia, and poor histologic subgroups
Number of subjects: 130
Study 9250802 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of fever
Number of subjects: 130
Study 9250802 — intervention group
Group type: EXPERIMENTAL
Intervention: Absence of all four significant factors (fever, spleen involvement, leukopenia, poor histologic subgroups)
Number of subjects: 130
Study 8496218 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical reduction
Number of subjects: 127
Study 8496218 — intervention group
Group type: COMPARATOR
Intervention: Medial displacement osteotomy
Number of subjects: 127
Study 3327354 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin G
Number of subjects: 457
Study 3327354 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 457
Study 27673505 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (0.25 μg/kg/h)
Number of subjects: 80
Study 27673505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 27031850 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab in combination with chemotherapy
Number of subjects: 774
Study 27031850 — intervention group
Group type: COMPARATOR
Intervention: Placebo in combination with chemotherapy
Number of subjects: 774
Study 27031850 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 774
Study 24938769 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management care in addition to standard emergency care (1 to 3 times during their stay and after 1, 3, and 5 months)
Number of subjects: 250
Study 24938769 — intervention group
Group type: COMPARATOR
Intervention: Standard emergency care only
Number of subjects: 250
Study 24938769 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management care
Number of subjects: 250
Study 24938769 — intervention group
Group type: COMPARATOR
Intervention: Standard emergency care
Number of subjects: 250
Study 22008871 — intervention group
Group type: EXPERIMENTAL
Intervention: Semont's liberatory maneuver (SLM)
Number of subjects: 342
Study 22008871 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 342
Study 20463113 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 52
Study 20463113 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 52
Study 20463113 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 18354844 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 2113
Study 18354844 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of natalizumab and interferon beta
Number of subjects: 2113
Study 18354844 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta
Number of subjects: 2113
Study 15355747 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 15355747 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 0
Study 15355747 — intervention group
Group type: EXPERIMENTAL
Intervention: COX-2 inhibitors
Number of subjects: 0
Study 11528361 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral E2 valerate (2 mg) + cyproterone acetate (1 mg)
Number of subjects: 41
Study 11528361 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E2 (1.5 mg) + oral medroxyprogesterone acetate (5 mg)
Number of subjects: 41
Study 11528361 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 41
Study 9415511 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (25 mg)
Number of subjects: 15
Study 9415511 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 15
Study 9415511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 8119607 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal vibroacoustic stimulation (5 seconds, 75 Hz frequency, 74 dB intensity)
Number of subjects: 100
Study 8119607 — intervention group
Group type: COMPARATOR
Intervention: Standard nonstress test
Number of subjects: 100
Study 8119607 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal vibroacoustic stimulation
Number of subjects: 100
Study 3819804 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose FAC chemotherapy (100% to 260% higher than standard FAC)
Number of subjects: 59
Study 3819804 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose FAC chemotherapy
Number of subjects: 59
Study 3819804 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose FAC chemotherapy
Number of subjects: 59
Study 30899530 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 µg/day)
Number of subjects: 400
Study 30899530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 29989857 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity‐modulated radiation therapy (IMRT)
Number of subjects: 278
Study 29989857 — intervention group
Group type: COMPARATOR
Intervention: Standard four‐field radiation therapy (RT)
Number of subjects: 278
Study 26620248 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once a day
Number of subjects: 449
Study 26620248 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 449
Study 25179871 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention focused on colorectal cancer screening, physical activity, and multi-vitamin intake
Number of subjects: 692
Study 25179871 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention
Number of subjects: 692
Study 22894573 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocriplasmin (125 μg)
Number of subjects: 652
Study 22894573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 652
Study 21158971 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Foods North (HFN) intervention programme implemented over 12 months, combining behaviour change and environmental strategies.
Number of subjects: 0
Study 17362050 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemotherapy approaches
Number of subjects: 40
Study 17362050 — intervention group
Group type: EXPERIMENTAL
Intervention: Newer cytotoxic chemotherapies and biological agents
Number of subjects: 40
Study 17362050 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy
Number of subjects: 40
Study 15671706 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored mail intervention
Number of subjects: 1044
Study 15671706 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored mail plus telephone intervention
Number of subjects: 1044
Study 15671706 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored telephone intervention
Number of subjects: 1044
Study 15671706 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored telephone and mail intervention
Number of subjects: 1044
Study 15671706 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1044
Study 11057934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydration
Number of subjects: 81
Study 11057934 — intervention group
Group type: COMPARATOR
Intervention: Oral hydration
Number of subjects: 81
Study 9031445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ardeparin 50 anti-Xa U/kg s.c. BID
Number of subjects: 860
Study 9031445 — intervention group
Group type: COMPARATOR
Intervention: Warfarin (adjusted-dose, INR 2.0 to 3.0)
Number of subjects: 860
Study 9031445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ardeparin 25 anti-Xa U/kg s.c. BID
Number of subjects: 860
Study 9031445 — intervention group
Group type: EXPERIMENTAL
Intervention: Ardeparin 35 anti-Xa U/kg s.c. BID
Number of subjects: 860
Study 9031445 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 860
Study 8295037 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training (n = 25, 15-minute daily program at the workplace for 6 months)
Number of subjects: 50
Study 8295037 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 25, not specified)
Number of subjects: 50
Study 3554702 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin (12 Gm/day)
Number of subjects: 72
Study 3554702 — intervention group
Group type: COMPARATOR
Intervention: Cefamandole (6 Gm/day)
Number of subjects: 72
Study 31749047 — intervention group
Group type: EXPERIMENTAL
Intervention: Navilas laser (OD-OS, 577 nm)
Number of subjects: 16
Study 31749047 — intervention group
Group type: COMPARATOR
Intervention: Conventional multispot laser (Quantel Medical, 577 nm)
Number of subjects: 16
Study 30138685 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (15–30 mg/day) and albumin (40 g/15 days)
Number of subjects: 196
Study 30138685 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine and albumin
Number of subjects: 196
Study 30138685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 28256022 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG probiotic enteric regimen
Number of subjects: 0
Study 28256022 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 25124829 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance and therapist adherence in successful treatments
Number of subjects: 61
Study 25124829 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance and therapist adherence in treatment failure
Number of subjects: 61
Study 25124829 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists' competence
Number of subjects: 61
Study 25124829 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance
Number of subjects: 61
Study 25124829 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists' adherence and competence
Number of subjects: 61
Study 25124829 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic alliance within one session
Number of subjects: 61
Study 23968628 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain packaging (two plainest packages)
Number of subjects: 220
Study 23968628 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-smokers
Number of subjects: 220
Study 23968628 — intervention group
Group type: COMPARATOR
Intervention: Original package
Number of subjects: 220
Study 23968628 — intervention group
Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 220
Study 21625533 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation via nasal cannulae for 72 hours
Number of subjects: 289
Study 21625533 — intervention group
Group type: COMPARATOR
Intervention: Control (room air, oxygen given only if clinically indicated)
Number of subjects: 289
Study 19102857 — intervention group
Group type: EXPERIMENTAL
Intervention: Admission plasma B-type natriuretic peptide (BNP)
Number of subjects: 134
Study 19102857 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary capillary wedge pressure (PCWP)
Number of subjects: 134
Study 16492320 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% 40 mL injected when nerve stimulation elicited a distal motor response
Number of subjects: 50
Study 16492320 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.75% 30 mL injected (7 mL to musculocutaneous nerve and 23 mL to median, ulnar or radial nerves)
Number of subjects: 50
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 27
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Almotriptan 12.5 mg
Number of subjects: 27
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Frovatriptan 2.5 mg
Number of subjects: 27
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5 mg
Number of subjects: 27
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 27
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg
Number of subjects: 27
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg
Number of subjects: 27
Study 14613361 — intervention group
Group type: EXPERIMENTAL
Intervention: Naratriptan 2.5 mg
Number of subjects: 27
Study 10857893 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) administered when monocytopenia (<150/microl) appeared on days 6 to 8 after chemotherapy (group A)
Number of subjects: 60
Study 10857893 — intervention group
Group type: COMPARATOR
Intervention: Granulocyte colony-stimulating factor (G-CSF) administered when neutropenia (<1,000/microl) or leukopenia (<2,000/microl) appeared after chemotherapy (group B)
Number of subjects: 60
Study 9086691 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based exercise (3 supervised sessions/week for 26 weeks, then 2 sessions/week)
Number of subjects: 49
Study 9086691 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise (30 min/day, 5 days/week, all exercise in home environment)
Number of subjects: 49
Study 8227484 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodinated glycerol (60 mg four times daily; n = 16)
Number of subjects: 29
Study 8227484 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 29
Study 30835643 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Cognitive Behavioral Therapy (BCBT)
Number of subjects: 120
Study 30835643 — intervention group
Group type: COMPARATOR
Intervention: Drug education (Control)
Number of subjects: 120
Study 29934099 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg thrice daily
Number of subjects: 40
Study 29934099 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 27194199 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocodone ER (15-90 mg every 12 hours)
Number of subjects: 182
Study 24686105 — intervention group
Group type: EXPERIMENTAL
Intervention: Website advertising
Number of subjects: 0
Study 24686105 — intervention group
Group type: EXPERIMENTAL
Intervention: Poster advertising
Number of subjects: 0
Study 24686105 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based advertising
Number of subjects: 0
Study 24686105 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health worker referrals
Number of subjects: 0
Study 24686105 — intervention group
Group type: EXPERIMENTAL
Intervention: Advertising online, via posters, and on a local radio station
Number of subjects: 0
Study 24686105 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturation advertising across many sources
Number of subjects: 0
Study 22538330 — intervention group
Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 1794
Study 22538330 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1794
Study 20109340 — intervention group
Group type: EXPERIMENTAL
Intervention: TC regimen (docetaxel plus carboplatin)
Number of subjects: 58
Study 20109340 — intervention group
Group type: COMPARATOR
Intervention: FC regimen (5-fluorouracil plus carboplatin)
Number of subjects: 58
Study 18037355 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral videotape
Number of subjects: 138
Study 18037355 — intervention group
Group type: COMPARATOR
Intervention: Standard instructional videotape
Number of subjects: 138
Study 15828970 — intervention group
Group type: EXPERIMENTAL
Intervention: Translation preceding disorientation
Number of subjects: 0
Study 15828970 — intervention group
Group type: EXPERIMENTAL
Intervention: Disorientation preceding translation
Number of subjects: 0
Study 12523448 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants told that the civilian car crashed
Number of subjects: 2
Study 12523448 — intervention group
Group type: COMPARATOR
Intervention: Participants not told that the civilian car crashed
Number of subjects: 2
Study 12523448 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants told that the police car crashed
Number of subjects: 2
Study 12523448 — intervention group
Group type: COMPARATOR
Intervention: Participants not told that the police car crashed
Number of subjects: 2
Study 10618944 — intervention group
Group type: EXPERIMENTAL
Intervention: succinylcholine 0.5 mg kg‐1
Number of subjects: 60
Study 10618944 — intervention group
Group type: EXPERIMENTAL
Intervention: succinylcholine 0.25 mg kg‐1
Number of subjects: 60
Study 10618944 — intervention group
Group type: COMPARATOR
Intervention: normal saline
Number of subjects: 60
Study 7546679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin every 12 h for 10 days
Number of subjects: 59
Study 7546679 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg amoxicillin every 8 h for 10 days
Number of subjects: 59
Study 7546679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin at 12 h before surgery
Number of subjects: 59
Study 7546679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin at 8 h before surgery
Number of subjects: 59
Study 7546679 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg amoxicillin at 6 h before surgery
Number of subjects: 59
Study 7546679 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (acute and chronic sinusitis)
Number of subjects: 59
Study 2020925 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of calcitonin 0.5 mg by intradermic route
Number of subjects: 6
Study 2020925 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous administration of calcitonin 0.5 mg
Number of subjects: 6
Study 7340377 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg of morphine in 10 ml of saline (n = 15)
Number of subjects: 42